Vigil Neuroscience, Inc.
VIGLDelisted Aug 5, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001827087
Vigil Neuroscience, Inc. was delisted on Aug 5, 2025; its insiders filed their last Form 4 on Aug 7, 2025; 78 institutions reported holding it in 13F filings for Q2 2025, worth $265.8M in total; no superinvestor held it.
13F holders, Q4 2024
Institutional positions in Vigil Neuroscience, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 51
- +1 vs. Q3 2024
- Shares held
- 22.6M
- −855.5K (−3.6%) vs. Q3 2024
- Total value
- $38.4M
- −$41.3M (−51.8%) vs. Q3 2024
- New holders
- 12
- 19 more added
- Sold out
- 11
- 11 more reduced
2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting VIGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 2 | $4.55K |
| Q2 2025 | 78 | $265.8M |
| Q1 2025 | 50 | $44.5M |
| Q4 2024 | 51 | $38.4M |
| Q3 2024 | 52 | $94.2M |
| Q2 2024 | 58 | $104.5M |
| Q1 2024 | 54 | $90.5M |
| Q4 2023 | 46 | $84.4M |
| Q3 2023 | 45 | $137.7M |
| Q2 2023 | 47 | $242.1M |
| Q1 2023 | 41 | $245.4M |
| Q4 2022 | 37 | $312.3M |
| Q3 2022 | 33 | $222.7M |
| Q2 2022 | 35 | $44.6M |
| Q1 2022 | 47 | $125.1M |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Vigil Neuroscience, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 1 | $2 | 0.00% | −282−99.6% | Reduced |
| Point72 (DIFC) Ltd | 7 | $12 | 0.00% | 00.0% | Unchanged |
| Morgan Stanley | 11 | $19 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 228 | $388 | 0.00% | +228 | New |
| Federated Hermes, Inc. | 313 | $532 | 0.00% | +115+58.1% | Added |
| JPMorgan Chase & Co | 382 | $649 | 0.00% | −32−7.7% | Reduced |
| R Squared Ltd | 910 | $1.55K | 0.00% | +910 | New |
| Bank of America Corp | 1,097 | $1.86K | 0.00% | −22,366−95.3% | Reduced |
| Tower Research Capital LLC (TRC) | 8,934 | $15.2K | 0.00% | +5,422+154.4% | Added |
| Point72 Asia (Singapore) Pte. Ltd. | 10,836 | $18.4K | 0.00% | −851−7.3% | Reduced |
| Engineers Gate Manager LP | 13,695 | $23.3K | 0.00% | +13,695 | New |
| ADAR1 Capital Management, LLC | 15,543 | $26.4K | 0.01% | −6,194−28.5% | Reduced |
| Citigroup Inc | 18,130 | $30.8K | 0.00% | −30,253−62.5% | Reduced |
| American Century Companies Inc | 19,970 | $33.9K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 24,120 | $41.0K | 0.00% | +8,358+53.0% | Added |
| Acadian Asset Management LLC | 37,905 | $63.0K | 0.00% | +37,905 | New |
| Jane Street Group, LLC | 48,812 | $83.0K | 0.00% | +48,812 | New |
| Barclays PLC | 64,049 | $108.9K | 0.00% | +19,436+43.6% | Added |
| Northern Trust Corp | 64,737 | $110.1K | 0.00% | +14,572+29.0% | Added |
| Two Sigma Advisers, LP | 69,100 | $117.5K | 0.00% | +49,000+243.8% | Added |
| State Street Corp | 69,139 | $117.5K | 0.00% | +28,400+69.7% | Added |
| Bridgeway Capital Management, LLC | 100,064 | $170.1K | 0.00% | −5,000−4.8% | Reduced |
| Verition Fund Management LLC | 107,536 | $182.8K | 0.00% | −22,494−17.3% | Reduced |
| Qube Research & Technologies Ltd | 108,482 | $184.4K | 0.00% | +65,897+154.7% | Added |
| Squarepoint Ops LLC | 113,596 | $193.1K | 0.00% | +113,596 | New |
| Two Sigma Investments, LP | 136,920 | $232.8K | 0.00% | +41,836+44.0% | Added |
| Boothbay Fund Management, LLC | 146,750 | $249.5K | 0.01% | +146,750 | New |
| Trustees of Columbia University in the City of New York | 192,973 | $328.1K | 0.05% | +192,973 | New |
| Susquehanna International Group, LLP | 212,664 | $361.5K | 0.00% | +212,664 | New |
| Geode Capital Management, LLC | 228,524 | $388.6K | 0.00% | +2,441+1.1% | Added |
| Point72 Asset Management, L.P. | 250,000 | $425.0K | 0.00% | −1,350,000−84.4% | Reduced |
| Goldman Sachs Group Inc | 256,642 | $436.3K | 0.00% | +256,642 | New |
| Marshall Wace, LLP | 266,895 | $453.7K | 0.00% | +122,853+85.3% | Added |
| ArrowMark Colorado Holdings LLC | 289,460 | $492.1K | 0.01% | 00.0% | Unchanged |
| Blair William & Co | 323,900 | $550.6K | 0.00% | +323,900 | New |
| Millennium Management LLC | 343,814 | $584.5K | 0.00% | +65,058+23.3% | Added |
| Renaissance Technologies LLC | 367,300 | $624.4K | 0.00% | +321,300+698.5% | Added |
| BlackRock, Inc. | 420,702 | $715.2K | 0.00% | −1,845−0.4% | Reduced |
| Rock Springs Capital Management LP | 471,958 | $802.3K | 0.03% | 00.0% | Unchanged |
| Woodline Partners LP | 488,756 | $830.9K | 0.01% | +344,614+239.1% | Added |
| Ikarian Capital, LLC | 500,000 | $850.0K | 0.24% | +500,000 | New |
| Standard Life Aberdeen plc | 528,472 | $898.4K | 0.00% | +293,461+124.9% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 560,595 | $953.0K | 0.64% | 00.0% | Unchanged |
| Ensign Peak Advisors, Inc | 703,116 | $1.20M | 0.00% | +97,580+16.1% | Added |
| Vanguard Group Inc | 975,473 | $1.66M | 0.00% | +70,742+7.8% | Added |
| 683 Capital Management, LLC | 1,400,000 | $2.38M | 0.23% | +180,420+14.8% | Added |
| Sphera Funds Management Ltd. | 1,502,429 | $2.55M | 0.47% | −145,175−8.8% | Reduced |
| Citadel Advisors LLC | 1,507,192 | $2.56M | 0.00% | +64,724+4.5% | Added |
| BVF Inc | 1,813,633 | $3.08M | 0.10% | 00.0% | Unchanged |
| Siren, L.L.C. | 1,991,038 | $3.38M | 0.15% | 00.0% | Unchanged |
| Atlas Venture Life Science Advisors, LLC | 5,836,874 | $9.92M | 1.21% | 00.0% | Unchanged |
| Deep Track Capital, LP | 0 | $0 | 0.00% | −1,553,996−100.0% | Sold out |
| StemPoint Capital LP | 0 | $0 | 0.00% | −743,719−100.0% | Sold out |
| OrbiMed Advisors LLC | 0 | $0 | 0.00% | −448,891−100.0% | Sold out |
| Walleye Capital LLC | 0 | $0 | 0.00% | −119,792−100.0% | Sold out |
| Sherbrooke Park Advisers LLC | 0 | $0 | 0.00% | −26,329−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Catalyst Funds Management Pty Ltd | 0 | $0 | 0.00% | −4,100−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −2,086−100.0% | Sold out |
| Royal Bank of Canada | 0 | $0 | 0.00% | −471−100.0% | Sold out |
| Nisa Investment Advisors, LLC | 0 | $0 | 0.00% | −45−100.0% | Sold out |
| Gotham Asset Management, LLC | 0 | $0 | 0.00% | −5,933−100.0% | Sold out |
| Northpond Ventures, LLC | – | – | – | – | Not filed |
| PEAK6 Investments LLC | – | – | – | – | Not filed |